Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
Thyroglobulin is a protein made by normal thyroid cells and by most thyroid cancers that arise from those cells. It is released into the bloodstream in small amounts when the thyroid is present and healthy, and it can rise when thyroid tissue is inflamed, injured, or growing.
Doctors measure thyroglobulin in blood to track thyroid tissue over time, especially after treatment for certain thyroid cancers. Because antibodies against thyroglobulin can interfere with some test methods, a companion test for anti‑thyroglobulin antibodies is often ordered at the same time to help interpret results accurately.
If you have had surgery and other treatment for differentiated thyroid cancer, thyroglobulin helps your care team monitor for remaining or returning thyroid tissue. It can be checked during routine follow‑up visits, sometimes under thyroid‑stimulating hormone (TSH) stimulation, to improve the test’s ability to detect disease. It may also help your team understand changes seen on imaging or symptoms you report.
This test is not used to screen people without thyroid problems for cancer. Results can be affected by antibodies, supplements, and the specific laboratory method used. Understanding these limits, and pairing the result with your history, medications, imaging, and other labs, helps your clinician decide what, if anything, needs to happen next.
Your result is interpreted in the context of your thyroid history. If your thyroid has been completely removed and treated, very low or undetectable values may be expected over time; a rising pattern can prompt repeat testing or imaging. If you still have a thyroid, low‑level thyroglobulin can be normal, and temporary increases can occur after procedures, inflammation, or changes in thyroid stimulation.
Antibodies to thyroglobulin can make some methods read falsely low or high. When antibodies are present, your clinician may rely on the antibody trend, use an assay that is less affected, or interpret thyroglobulin trends cautiously. Because different laboratories and methods are not interchangeable, try to use the same lab for follow‑up testing when possible. If a result is unexpected, your clinician may repeat the test, review medications and supplements, or plan additional evaluation.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Antibodies that bind thyroglobulin can interfere with many immunoassays, causing falsely low or occasionally high readings. Labs often measure these antibodies with the thyroglobulin test to guide interpretation.
Procedures on the thyroid, radioiodine therapy, or thyroiditis can temporarily increase thyroglobulin. Your clinician may wait an appropriate interval after such events before testing to avoid misleading results.
Higher thyroid‑stimulating hormone levels, whether from medication adjustment or recombinant TSH, can increase circulating thyroglobulin. Results are interpreted based on whether testing was done under stimulation or on suppression.
High‑dose biotin and some supplements can interfere with certain immunoassays, leading to inaccurate results. Tell your care team about all supplements; you may be asked to stop biotin before testing.
Thyroglobulin results can vary between laboratories and test platforms. For long‑term monitoring, using the same lab and method helps ensure that trends over time are meaningful.
Pregnancy, postpartum changes, and shifts in iodine or thyroid hormone status can affect thyroglobulin production and levels. Your clinician will interpret results with these factors in mind.
References